Lorenzo Nevi
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: July 27, 2025
Sapheno-Femoral Junction Aneurysm: Single Centre Experience With Technical Notes and Histological Analysis.
Journal: Vascular and endovascular surgery
Published: April 14, 2025
Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strength.
Journal: Metabolism: clinical and experimental
Published: March 14, 2025
Rewriting the MASLD-associated hepatocellular carcinoma script: Targeting epigenetics and metabolism.
Journal: International journal of cancer
Published: February 20, 2025
Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting.
Journal: International journal of molecular sciences
Published: October 13, 2023
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity.
Journal: Journal of advanced research
Published: August 17, 2023
MACanalyzeR scRNAseq analysis tool reveals PPARγHIGH/GDF15HIGH lipid-associated macrophages facilitate thermogenic expansion in BAT.
Journal: Nature communications
Published: July 21, 2023
Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis.
Journal: Drug delivery and translational research
Published: February 04, 2022
Islet Regeneration and Pancreatic Duct Glands in Human and Experimental Diabetes.
Journal: Frontiers in cell and developmental biology
Published: November 12, 2021
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential.
Journal: Journal of hepatology
Published: January 25, 2021
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells.
Journal: Scientific reports
Published: March 19, 2020
DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: February 23, 2020
Last Updated: 09/26/2026